본문 바로가기

Stroke Severity in Patients on Non-Vitamin K Antagonist Oral Anticoagulants with a Standard or Insufficient Dose

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
THROMBOSIS AND HAEMOSTASIS118(12) · pp.2145 · 2018
피인용
Web of Science 15Scopus 14
FWCI (Scopus)
0.38
JCR IF
JCR 2017 4.952
ISSN
0340-6245

저자

  1. Jung, Yo Han제1저자Department of Neurology, Changwon Fatima Hospital, Changwon, South Korea
  2. Choi, Hye-YeonDepartment of Neurology, Kyung Hee University, School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea
  3. Lee, Kyung-YulDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University, College of Medicine, Seoul, South Korea
  4. Cheon, KyeongyeolDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University, College of Medicine, Seoul, South Korea
  5. Han, Sang WonDepartment of Neurology, Sanggye Paik Hospital, Inje University, College of Medicine, Seoul, South Korea
  6. Park, Joong HyunDepartment of Neurology, Sanggye Paik Hospital, Inje University, College of Medicine, Seoul, South Korea
  7. 조한진Department of Neurology, Pusan National University Hospital, Pusan National University, College of Medicine, Biomedical Research Institute, Busan, South Korea
  8. Park, Hyung JongDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
  9. Nam, Hyo SukDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
  10. Heo, Ji HoeDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
  11. Lee, Hye SunBiostatistics Collaboration Unit, Yonsei University, College of Medicine, Seoul, South Korea
  12. Kim, Young Dae교신저자Department of Neurology, Yonsei University, College of Medicine, Seoul, South Korea

초록

Background The stroke severity or functional outcomes could differ because the efficacy of non-vitamin K antagonist oral anticoagulants (NOACs) could be different according to the dose. We investigated whether there was any difference in the stroke outcomes in patients with non-valvular atrial fibrillation (NVAF) by their prior medication status, including standard-dosed versus under-dosed NOACs. Materials and Methods We enrolled 858 patients with acute ischaemic stroke with chronic NVAF admitted at six hospitals in Korea. We categorized their prior medication status as follows: (1) no anti-thrombotics (n = 219), (2) only anti-platelet (n = 347), (3) warfarin with a sub-therapeutic intensity (n = 185), (4) warfarin with a therapeutic intensity (n = 37), (5) under-dosed NOAC (n = 27) and (6) standard-dosed NOAC (n = 43). We compared the initial stroke severity between groups. Results Among the 858 patients, the patients on standard-dosed NOACs had the lowest initial National Institute of Health Stroke Scale (NIHSS) score, followed by those on warfarin with a therapeutic intensity and those on only anti-platelet (p < 0.05). Multivariate analysis demonstrated that the NIHSS score was significantly low in the patients on warfarin with a therapeutic intensity (B, -5.602; 95% confidence interval [CI], -8.636 to -2.568; p < 0.001) or those on standard-dosed NOACs (B, -3.588; 95% CI, -6.405 to -0.771; p = 0.013), while there was no difference in the NIHSS score between the patients not taking any anti-thrombotics and those on warfarin with a subtherapeutic intensity or under-dosed NOACs. Conclusion Use of warfarin with a therapeutic intensity or standard-dosed NOACs was associated with a relatively mild stroke in the patients with NVAF.

키워드

strokeatrial fibrillationoutcomeNOACACUTE ISCHEMIC-STROKEPARTIAL THROMBOPLASTIN TIMEATRIAL-FIBRILLATIONASIAN PATIENTSANTITHROMBOTIC TREATMENTWARFARINPREVENTIONDABIGATRAN

식별자

Scopus EID
2-s2.0-85057756146
WoS UID
000451853100015